Literature DB >> 24562763

[Traveling with immunosuppression].

G Birkenfeld1.   

Abstract

The rapidly increasing number of patients with immunosuppression is followed by their expectation to lead-as much as possible-a "normal" life, including long-distance travel. The advice and preventive measures for diseases associated with travelling depend overall on the mode of the patient's immunosuppression. This report explains the individual preventive possibilities, limits and risks for travellers with asplenia, common variable immunodeficiency, chronic inflammatory bowel and rheumatic diseases, HIV, as well as for patients having undergone solid organ or bone marrow transplantation or chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24562763     DOI: 10.1007/s00108-013-3367-8

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  21 in total

1.  Challenging scenarios in a travel clinic: advising the complex traveler.

Authors:  Kathryn N Suh; Maria D Mileno
Journal:  Infect Dis Clin North Am       Date:  2005-03       Impact factor: 5.982

2.  Late diagnosis of HIV in Europe: definitional and public health challenges.

Authors:  A Adler; S Mounier-Jack; R J Coker
Journal:  AIDS Care       Date:  2009-03

3.  Immunogenicity of pneumococcal vaccine in renal transplant recipients--three year follow-up of a randomized trial.

Authors:  D Kumar; B Welsh; D Siegal; M Hong Chen; A Humar
Journal:  Am J Transplant       Date:  2007-01-11       Impact factor: 8.086

4.  Increasing rates of malarial fever with deteriorating immune status in HIV-1-infected Ugandan adults.

Authors:  N French; J Nakiyingi; E Lugada; C Watera; J A Whitworth; C F Gilks
Journal:  AIDS       Date:  2001-05-04       Impact factor: 4.177

5.  Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study.

Authors:  J Whitworth; D Morgan; M Quigley; A Smith; B Mayanja; H Eotu; N Omoding; M Okongo; S Malamba; A Ojwiya
Journal:  Lancet       Date:  2000-09-23       Impact factor: 79.321

6.  Persistence of seroprotection 10 years after primary hepatitis A vaccination in an unselected study population.

Authors:  Pamela Rendi-Wagner; Maria Korinek; Birgit Winkler; Michael Kundi; Herwig Kollaritsch; Ursula Wiedermann
Journal:  Vaccine       Date:  2006-09-18       Impact factor: 3.641

7.  Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices.

Authors:  Charles E Rupprecht; Deborah Briggs; Catherine M Brown; Richard Franka; Samuel L Katz; Harry D Kerr; Susan M Lett; Robin Levis; Martin I Meltzer; William Schaffner; Paul R Cieslak
Journal:  MMWR Recomm Rep       Date:  2010-03-19

8.  Late presentation for HIV diagnosis and care in Germany.

Authors:  A Zoufaly; M an der Heiden; U Marcus; C Hoffmann; Hj Stellbrink; L Voss; J van Lunzen; O Hamouda
Journal:  HIV Med       Date:  2011-11-07       Impact factor: 3.180

9.  International travel and exposure risks in solid-organ transplant recipients.

Authors:  Daniel Z Uslan; Robin Patel; Abinash Virk
Journal:  Transplantation       Date:  2008-08-15       Impact factor: 4.939

10.  Increased risk for severe malaria in HIV-1-infected adults, Zambia.

Authors:  Victor Chalwe; Jean-Pierre Van geertruyden; Doreen Mukwamataba; Joris Menten; John Kamalamba; Modest Mulenga; Umberto D'Alessandro
Journal:  Emerg Infect Dis       Date:  2009-05       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.